Pharmaceutical industry – Page 46

Business
Bayer wins race to buy Merck & Co consumer care

2014-05-09T00:00:00Z

$14bn deal will make Aspirin inventor the number two over-the-counter healthcare company
Business
UK regulator warning over online herbal remedies

2014-05-07T00:00:00Z

Products found to contain toxic metals or undeclared prescription-only drugs
Business
Insider trading allegations stall Sun–Ranbaxy deal

2014-05-07T00:00:00Z

Companies deny wrongdoing in lead-up to merger announcement
Business
Forest Labs buys Furiex for bowel drug

2014-05-02T00:00:00Z

Firm will immediately sell on other assets to Royalty Pharma
Business
Pfizer courts AstraZeneca megamerger

2014-04-29T00:00:00Z

AZ rebuffs public dealmongering
Business
Valeant launches hostile bid for Allergan

2014-04-29T00:00:00Z

Botox maker swallows ‘poison pill’ in defence
Opinion
Engineering serendipity

2014-04-25T00:00:00Z

It takes more than random stumbling to find new reactions, says Derek Lowe
Business
Generics triumph in anti-inflammatory patent battle

2014-04-25T00:00:00Z

Pfizer settles deals to allow copycat celecoxib
Business
$25bn-plus trade sharpens pharma giants’ focus

2014-04-25T00:00:00Z

Novartis’ asset swaps with GSK and Eli Lilly are the latest steps in an ongoing streamlining process
Business
GSK corruption investigation widens

2014-04-23T00:00:00Z

BBC investigation airs allegations of misconduct in Poland
Business
Missing safety risk emails draw $9bn Actos fine

2014-04-11T00:00:00Z

Judge finds absence of Takeda documentation in bladder cancer case ‘disturbing’
Business
Sun set on Ranbaxy rescue

2014-04-09T00:00:00Z

Acquiring beleaguered firm will create India’s biggest pharmaceutical company
Business
GSK investigates bribery claims in the Middle East

2014-04-09T00:00:00Z

Leaked emails claim GlaxoSmithKline bribed Iraqi doctors and healthcare officials
Business
Contamination troubles strike GSK

2014-04-08T00:00:00Z

GlaxoSmithKline is warned over contamination at an Ireland plant, and has recalled Alli from US retailers over tampering concerns.
Business
Lilly wins cancer drug patent dispute

2014-04-07T00:00:00Z

Alimta patent will last until 2022 after US court rules in Lilly’s favour
Business
Pharma giants plan new public–private collaborations

2014-04-03T00:00:00Z

AstraZeneca and GSK will partner with UK academics to work on early drug discovery
Business
Baxter aims to divide and conquer

2014-03-28T00:00:00Z

Firm will split off its biopharmaceuticals business from medical products
Opinion
Known unknowns

2014-03-27T00:00:00Z

New molecules with unpredictable biological activity deserve sensible amounts of respect, says Derek Lowe
Business
AstraZeneca boosts open innovation efforts

2014-03-26T00:00:00Z

Web portal will make collaborative drug discovery easier
Business
$1.2bn J&J deceptive marketing fine overturned

2014-03-26T00:00:00Z

Supreme court reverses decision to fine firm over Risperdal promotion